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For the last 30 years a considerable part of my work has centered
round the problem of combining irradiation and surgery in the treatment of uterine cancer, both of
cervix and corpus. There was nothing unusual about the latter because radium in the uterus before
operation, or in the vagina after
operation, has been used by surgeons for many years. But as far as
carcinoma of the cervix was concerned the concept of operating on
irradiated tissues was considered
foolhardy to an extreme and was
condemned by such outstanding authorities at the time as the late
Victor Bonney of London and
Heyman of Radiumhemmet, Stockholm. The reasons for my determination to explore this field, and the
philosophy that activated the research, have been published elsewhere (Stallworthy, 1964; 1966).
Mr. Bonney, who was my chief in
London in 1936-1937, when I was
one of his last pupils, was interested in our Oxford research as
was Joe Vincent Meigs [late President of the Society of Pelvic Surgeons]. Both were sceptical of its
outcome and neither lived to see
the results. I will use two recent
cases to illustrate the following
four points:
1. That high doses of irradiation, though not a desirable prelude
to surgery, are not an absolute contraindication.
2. That the final criterion of
radiation response is not measured
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by exfoliative cytology, but by the
length of time the patient lives
without further evidence of tumour formation.
3. That planned combined therapy ab initio is less traumatic for
both patient and surgeon than
salvage surgery after failed irradiation.
4. That teamwork involving radiotherapist and surgeon is essential for success.
Two Case Histories
The first illustrative case concerns an adenocarcinoma of the
cervix in an English woman aged
34 and para 3. This was in July
1963. She had a stage 2 carcinoma
of the cervix, reasonably well differentiated and graded Broder 2.
She was referred to the radiotherapy department at Liverpool, where
a total dose of 9,000 mg hours of
radium was given to the cervix and
vaginal vault. This was followed by
high energy irradiation with cobalt
60 to a total dose of 5,520 rads.
Two and a half years later bleeding recurred, and examination confirmed the presence of invasive
cancer. The position looked hopeless because of the so-called recurrence after very high dose radiation therapy.
The patient was transferred to
Oxford for a second opinion, and
as the tumour was clinically operable and the patient only 36 with
three children dependent upon her,

it was decided that she should be
given the only opportunity of survival now open to her. On 3-3-66
a Wertheim hysterectomy was performed with full appreciation of
the risks involved, particularly in
relation to necrosis and fistulae.
Examination of the surgical specimen demonstrated tumour cells in
the cervix, corpus, paracolpos, parametrium, and left obturator node.
Fortunately the postoperative progress was uneventful, and the patient nine months later is alive,
well, and caring for her family.
The second patient came from
America. She was aged 60, nulliparous, and in November, 1964,
had been treated in New York for
an adenocarcinoma of the cervix,
stage 3, and poorly differentiated.
A total dose of 5,300 mg hours
of radium application was given to
the cervix with associated high energy irradiation using cobalt 60
and a dose of 4,000 rads. She was
carefully followed up and on 10-165, just one year after treatment,
she was symptom-free but was admitted to hospital for a progress
study. The report was given: "Excellent response to radiotherapy."
The patient was an Englishwoman who had lived for some
years in New York where her husband had recently died, and she decided to return to Britain. Within
five months after the progress
study, there was a recurrence of
uterine pain and vaginal bleeding.
Active growth was demonstrated at
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curettage. Further irradiation was
considered useless and the prognosis looked grim. Her surgeon in
New York had given her a letter
of introduction to the Oxford Department, where on 4-18-66 a
Wertheim hysterectomy was performed, 19 months after the irradiation. Growth was demonstrated in
the cervix and in the parametrium,
but not in the corpus or the nodes.
Postoperative recovery was uneventful, and two months later the
patient, when reporting for her
follow-up examination, stated "I
feel human once again."
Discussion
The total series of post-irradiation Wertheims now performed at
Oxford since 1942 is 360, and the
fact that there have been only two
deaths and two ureteric fistulae has
clearly established that this is a safe
and practical procedure. In spite of
the increasing number of patients
similar to the two illustrated, who
are now referred for salvage, there
has not been a ureteric fistula for
many years. Two modifications of
the original Bonney technique, designed to protect the ureter and
bladder, have been described elsewhere (Stallworthy, 1964) and
have proved effective. One death
was due to pulmonary embolism
and the other to Asian influenza
with a fulminating septicaemia
which killed the patient within a
few hours the day before she was
due to go home.
The ideal in combined therapy is
for each case to be assessed by
both the radiotherapist and the
surgeon and for the treatment to
be planned from the beginning.
This has resulted in a 71 % fiveyear apparent cure rate in 188 patients operated upon after irradiation between 1950 and October
1961. Moreover, in the last three
years of _this study, nine of 15
patients with malignant nodes were
alive and well five years later, a
survival rate of 60% .
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It may well be, as suggested by
Powers ( 1964), that smaller doses
of preoperative irradiation would
prove effective. We have used doses
considered to be lethal by the radiotherapists, but proven not to be
in a high percentage of patients.
Dr. Powers has summarised the experimental evidence to support the
concept of preoperative irradiation,
and our considerable clinical material confirms his view. Recently Sir
Eric Riches ( 1965) has advocated
the same combination of therapy
in the treatment of malignant renal
tumours, and the available evidence, both experimental and clinical, indicates that the concept of
preoperative irradiation, which has
proved effective in the treatment of
tumours in the genito-urinary tract,
could be applied to the treatment
of cancer elsewhere.
We have much to learn before it
can be claimed with truth that the
treatment of cervical cancer has
been perfected, but great progress
has been made. Combined therapy,
carefully planned for each patient
when technically possible, has eliminated irradiation failures with socalled recurrent uterine cancer. It
avoids the necessity of salvage operations after high dose irradiation
and greatly improves the results of
radical surgery.
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